The Deal
The Deal
The Deal podcast network brings The Deal’s award winning coverage in M&A, activist investing, private equity and restructuring to your airwaves. With a suite of offerings, including Activist Investing Today (hosted by Senior Editor Ronald Orol), Drinks With The Deal (hosted by Senior Writer David Marcus and Senior Reporter Bill Meagher), Behind The Buyouts (hosted by Senior Reporters Steve Gelsi, Nikitha Sattiraju and Senior Writer Chris Nolter) and Fresh Start (hosted by Senior Reporter Stephanie Gleason), The Deal’s podcast network is your go-to source for timely financial news and perspective.
Episodes
Mentioned books
Jan 6, 2022 • 24min
Drinks With The Deal: Covington's Catherine Dargan
Covington head of M&A and corporate Catherine Dargan discussed building her healthcare M&A practice, current issues in healthcare dealmaking and her approaches to diversity and inclusion and associate retention in this week's podcast.
Dec 16, 2021 • 20min
Drinks With The Deal: Eduardo Gallardo of Gibson Dunn
Eduardo Gallardo, co-chair of M&A and chair of the activist defense group at Gibson Dunn, discussed the universal proxy, the Williams case and more on this week's Drinks With The Deal podcast.
Dec 15, 2021 • 30min
Activist Investing Today: R5’s Mushkin on Dollar Tree, New Coke and Hain
Scott Mushkin, a consumer-focused researcher, discussed Mantle Ridge’s contest at Dollar Tree and compared the discount retailer’s new pricing strategy to Coca-Cola’s failed ‘New Coke’ endeavor.
Dec 9, 2021 • 25min
Drinks With The Deal: Gregory Varallo of Bernstein Litowitz
Greg Varallo, partner at Bernstein Litowitz in Wilmington, discussed the switch from representing companies to working with shareholders, Andy Bouchard's achievements as Chancellor, his love of hunting, poker and the American University of Rome and more in this week's episode of the podcast.
Dec 2, 2021 • 29min
Drinks With The Deal: Willkie's Tariq Mundiya
Tariq Mundiya, the head of litigation at Willkie Farr & Gallagher, discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.
Nov 18, 2021 • 20min
Drinks With The Deal: Squire Patton Boggs' James Barresi
James 'Jim' Barresi, who heads the financial services practice at Squire Patton Boggs, explains how his time as an in-house lawyer at US Bancorp in the 1990s has shaped his approach to private practice and how he works with clients who are considering a deal.
Nov 4, 2021 • 44min
Drinks With The Deal: Spirits Experts David Wondrich and Noah Rothbaum
On the latest edition of Drinks With The Deal, David Wondrich and Noah Rothbaum discuss their work editing the new Oxford Companion to Spirits and Cocktails, which considers at length the companies, entrepreneurs and trends that have driven the alcohol business.
Oct 28, 2021 • 26min
Drinks With The Deal: Edward Zimmerman of Lowenstein Sandler
Ed Zimmerman discusses building the tech group at Lowenstein Sandler and his commitment to social justice on the latest Drinks With The Deal podcast.
Oct 25, 2021 • 50min
Fresh Start: Professor Melissa Jacoby
Professor Melissa Jacoby of University of North Carolina at Chapel Hill discusses the limits of bankruptcy in handling mass tort cases and the recent filings of Purdue Pharma LP and others on the latest episode of the Fresh Start podcast.
Oct 13, 2021 • 17min
Drinks With The Deal: Krishna Veeraraghavan of Paul Weiss
M&A lawyer Krishna Veeraraghavan talks about health care M&A and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.
